Abstract
Bisphenols are widely used as monomers and additives in plastic production. Thus, bisphenol A (BPA) and its most prominent substitutes have been detected in many environmental and human samples. This study proposes an online solid-phase extraction analytical methodology coupled to liquid chromatography with tandem mass spectrometry for the determination of six bisphenols (BPA and bisphenols F (BPF), S (BPS), AF (BPAF), B (BPB), and E (BPE)) in urine samples as an efficient and automated methodology. The method was developed and validated for all bisphenols with good recoveries (92–112%) and repeatability (RSD ≤ 10%) despite the variable matrix effects, except BPAF (which would require a dedicated internal standard), achieving method quantification limits in the 0.05–2.2 ng mL−1 range. The methodology was subsequently applied to 435 urine samples from a non-occupational exposure population (civil servants for the regional government) from Santiago de Compostela (Galicia, Spain). Only BPA, BPF, and BPS were positively detected; the last two presented higher detection frequencies than BPA. When the urinary concentrations are extrapolated to human intake and compared to the European Food Safety Agency (EFSA) tolerable daily intake (TDI) of 2 × 10−4 µg kg−1 day−1 (TDI), all BPA positively identified samples would surpass this threshold. Although no TDI exists currently for the other two identified bisphenols, it is evident that human exposure to bisphenols should be limited. Finally, the results stratification by gender revealed higher levels of exposure to BPF in the women group.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Bisphenols pose unique physical and chemical properties, such as clarity, durability, versatility, corrosion protection, mechanical strength, and thermal stability [1]. Thus, they have been largely used by industry in different applications, many of which are related to plastic production. In particular, bisphenol A (BPA) is the most popular bisphenol, being used as a monomer in polycarbonate plastics (70% of BPA global use) and epoxy resins (nearly 30% of total BPA production) [2].
Bisphenols can migrate from plastics to the environment, where they can be uptaken and bioaccumulated by living organisms [3, 4]. Similarly, human exposure to these compounds can also occur, with ingestion being the most significant route, attributed to migration from plastic packaging into consumable products, primarily food or drinking water [5, 6]. In addition, dermal contact or inhalation could also represent an important source of exposure [7, 8].
From a toxicological point of view, BPA has been classified as an endocrine-disrupting chemical [9]. High levels of exposure to BPA can lead to metabolic diseases, such as type 2 diabetes, hypertension, and elevated cholesterol [10, 11], or interference with the immune and reproductive system by hormonal interactions [12, 13]. In 2006, the European Food Safety Agency (EFSA) conducted the initial risk assessment of BPA, prompting the European Commission to establish concentration limitations, particularly focusing on products intended for infants and food contact materials [14, 15]. More recently, EFSA has decided to implement stricter limits on BPA in food contact materials, reducing the tolerable daily intake (TDI) from 4 µg kg−1 day−1 to 0.2 ng kg−1 day−1 effective from April 2023 [16]. Similarly, the US Environmental Protection Agency has set an oral reference dose of 0.05 mg kg−1 day−1 and formulated an action plan in 2010 to mitigate human exposure to BPA [17, 18]. Such restrictions have caused the emergence of other bisphenols aiming at replacing BPA in manufactured products, such as bisphenol F (BPF), bisphenol S (BPS), bisphenol AF (BPAF), bisphenol B (BPB), or bisphenol E (BPE), among others [19]. These compounds have similar properties to BPA; however, their potentially harmful effects on human health have not been deeply investigated [20,21,22]. In this context, the EFSA has set a migration rate limit of 0.05 mg kg−1 in food for BPS [23], but other BPA alternatives have not yet been investigated. Although in 2020, the German government proposed a restriction on BPA and structurally related analog bisphenols [24], the proposal was withdrawn with the intention to re-submit an updated report to ECHA in the upcoming years.
Once bisphenols enter the human body, a fraction can be absorbed and accumulated in different tissues, while another fraction is eliminated via urine and feces as the original chemical or/and as a metabolite [25,26,27]. Thus, the measurement of bisphenols and their metabolites in urine represents an appropriate approach to evaluate human exposure to these chemicals by human biomonitoring (HBM) studies [28, 29]. HBM can give a reliable and comprehensive picture that can be used to further understand population exposure to these chemicals, since the population data can be stratified by sex, age, etc. However, the analysis of urine can become very laborious and expensive. In particular, a sample preparation step for purification and concentration based on solid-phase extraction (SPE) is usually required [30] before the chromatographic analysis which can be rather time-consuming. Thus, the integration of automation and online extraction methodologies with chromatographic analysis is a major step forward. In this context, online SPE coupling with liquid chromatography tandem mass spectrometry (LC–MS/MS) is one of the best-suited approaches, as it maximizes sample throughput, while providing an adequate preconcentration and clean-up of the urine samples [31, 32].
Hence, the aim of this study was to develop a high throughput analytical methodology for the determination of six bisphenols (BPA, BPF, BPS, BPAF, BPB, and BPE) in urine samples, and, subsequently, use this method to explore human exposure to them. To this end, an online SPE-LC–MS/MS, after enzymatic deconjugation, method was developed and validated. Then, the method was employed to analyze a total of 435 urine samples from civil servants daily working in the city of Santiago de Compostela (Northwest Spain).
Materials and methods
Chemicals and reagents
Table S1 compiles information about the structure of target analytes. Analytical standards of BPA, BPAF, BPB, BPE, BPF, BPS, and creatinine and three deuterated analogues (BPA-d6, BPS-d8, and creatinine-d3) used as surrogate internal standards (ISs) were supplied by Sigma-Aldrich (San Luis, MO, USA). Analytical standards as sodium salts of BPA monosulfate (BPA-S), BPA bissulfate (BPA-DS), BPS monosulfate (BPS-S), BPF monosulfate (BPF-S), BPS β-D-glucuronide (BPS-G), and BPA bis-(β-D-glucuronide) (BPA-DG), and analytical standards of BPF β-D-glucuronide (BPF-G) and BPA β-D-glucuronide (BPA-G) were purchased from Toronto Research Chemicals (TRC, Nort York, ON, Canada).
LC–MS grade methanol (MeOH), LC–MS grade water (ultrapure water), LC–MS grade acetic acid, LC–MS grade formic acid, HCl solution (37%), NaOH (98%), β-glucuronidase (from Helix pomatia, type H2), ammonia solution in water (25%), NH3 in MeOH (7 N), NH4F (98%), NaCl (99.5%), Na2SO4 (99%), KCl (99%), NH4Cl (99.8%), CaCl2 (97%), urea (99.5%), and creatinine (98%) were supplied by Sigma-Aldrich. Sodium acetate was obtained from Fluka (Steinheim, Germany). KH2PO4 (99.5%) was supplied by PanReac (Chicago, IL, USA).
Urine collection
Urine samples were obtained through a volunteer recruitment campaign carried out in collaboration with the General Directorate for Public Health of the Galicia regional Government – Xunta de Galicia (Norwest Spain). The sampling lasted 3 weeks in September 2020, and 435 early morning urine (EMU) samples were collected from anonymized volunteers who work as public servants in the regional government administration in the city of Santiago de Compostela. Informed consent was obtained from all volunteers and stored properly. Ethical consent for the study was obtained from the Research Ethics Committee of the Xunta de Galicia (Code 2019/545). Short surveys were also filled out by each volunteer and the following information was collected: sex (male/female), age (in years), tobacco use (yes/no), and residential environment (urban [> 50,000 inhabitants]/suburban [500–50,000 inhabitants]/rural [< 500 inhabitants]). Table S2 summarizes sociodemographic details of the sampled population and the detailed information of all individual samples (sex, age, etc.) is compiled in the ZENODO repository (https://doi.org/10.5281/zenodo.10477935). After collection, urine samples were kept in the freezer at − 25 °C until being processed.
Sample pretreatment
The total concentration of the bisphenols was measured after deconjugation by incubation at 37 °C with the β-glucuronidase (from Helix pomatia, type H2) enzyme [33]. The deconjugation experimental conditions, β-glucuronidase concentration (250–850 units), and incubation time (1.5–4.5 h) were optimized by a design of experiments approach using a central composite design (experimental conditions detailed in Text S1).
Once optimal values were set, each sample was filtered through 0.45 µm PVDF syringe-driven filters (Millex, Merck Millipore). Then, 200 µL of filtered urine samples was adjusted to pH 5 with 80 µL of a sodium acetate buffer (1 mM), spiked with 700 units of β-glucuronidase (112 µL of a 5000 units solution in 0.2% NaCl), 20 ng mL−1 of the deuterated internal standards mixture (16 µL of a 1 ng µL−1 solution), and 392 µL of ultrapure water (total volume 800 µL). Then, samples were incubated at 37 °C for 5 h. Finally, samples were passed through a β-gone β-glucuronidase removal cartridge from Phenomenex (Torrance, CA, USA) in order to eliminate the enzyme and increase SPE and LC columns lifetime, filtered through 0.22 µm PVDF syringe-driven filters and injected into the online SPE-LC–MS/MS system. Urine samples were also employed to estimate urinary creatinine concentrations (analytical details are given in Text S2).
Analytical determination
The online SPE-LC–MS/MS system involves a sequential process coupling the SPE with the LC–MS/MS through a 10-port valve. This was carried out in an Agilent 1290 Infinity II (Santa Clara, CA, USA) binary solvent pump, for analysis, an Agilent 1260 Infinity II quaternary pump, for online SPE, a thermostatted LC column compartment, a Flexcube module, and a sample manager. MassHunter Data Acquisition and MassHunter Quantitative Analysis software were used for equipment control and data treatment, respectively. The LC system was interfaced to an Agilent 6495 LC/TQ triple quadrupole mass spectrometer. Figure 1 outlines the configuration used.
Each sample or standard was online solid-phase extracted on a Strata-X 25 µm online extraction cartridge (20 × 2.0 mm) from Phenomenex. A dual eluent system consisting of (A1) 15 mM of a sodium acetate buffer at pH 5 in ultrapure water and (B1) MeOH was employed in the quaternary pump. Chromatographic separation was performed on a Luna C18 (150 × 2 mm I.D., 3 µm particle size) column also from Phenomenex with a dual eluent system of (A2) 2 mM of NH4F in ultrapure water and (B2) 2 mM of NH4F in MeOH, at a flow rate of 0.2 mL min−1 (see Table 1 for detailed information on both gradients). Briefly, 500 µL of the deconjugated urine sample, after the pretreatment explained in the previous section, was loaded into the online SPE cartridge in 2 min (0% B1 at 1 mL min−1). After a clean-up step with 40% B1, the valve changed to Position 2 (at 7 min) and analytes were eluted towards the chromatographic column with the LC mobile phases. The LC gradient was maintained until 8 min at 2% B2 and then ramped to 100% B2 in 3.5 min, which was maintained for 4 min and finally returned to initial conditions (2% B2), with a total run time of 21 min. Simultaneously, the valve switched back to Position 1 at 15 min and the SPE cartridge was cleaned up with 100% B1 (3.5 min at 1 mL min−1) and then equilibrated at 0% B1 for the next injection (see details in Table 1).
A Jet Stream electrospray ionization (ESI) source operating in negative mode was the interface between the LC system and the 6495 LC/TQ triple quadrupole mass spectrometer at a fixed capillary and nozzle voltage of 2.5 and 0.5 kV, respectively. The iFunnel voltage was set at 60 V/70 V (high/low-pressure RF). Nitrogen was used as sheath gas at 12 L min−1 and 400 °C and also as desolvation gas at 14 L min−1 and 120 °C. Analyses were performed by MS/MS in selected reaction monitoring (SRM) mode using 166 V as fragmentor voltage. Table 2 summarizes the retention times (RT), SRM transitions (Qn), optimal collision energies (CE) for the target bisphenols, and internal standards. Three SRM transitions were recorded for each analyte, except for BPB and BPE for which only two transitions were obtained, and ion ratios were monitored in order to ensure proper identification of analytes [34]. Only one transition was recorded in the case of ISs.
Method performance
BPA and BPS were quantified using their surrogate analogues as IS. BPA-d6 was also used as IS for the remaining bisphenols (Table 2) as it provided better performance when compared to BPS-d8.
Calibration curves for the final method were prepared in ultrapure water and ranged from the MQL to 50 ng mL−1, IS level set to 20 ng mL−1. The lowest concentration of the calibration curve was selected as a function of the MQL for each analyte. Originally 11 standards were prepared in order to have a calibration curve with 11 points (0.1, 0.25, 0.5, 0.75, 1, 2.5, 5, 7.5, 10, 25, 50 ng mL−1 + 20 ng mL−1 of IS in all cases); however, this was only used for BPS. For the other compounds, the lowest level was selected depending on the respective MQL; thus, BPA and BPF calibration curves consisted of 6 points (2.5–50 ng mL−1) and BPB, BPE, and BPAF calibration curves consisted of 7 points (1–50 ng mL−1). Online SPE-LC–MS/MS method performance was investigated in terms of linearity, trueness, precision, method detection limits (MDL), and method quantification limits (MQL) (Table 3). Moreover, the slope and intercept estimated and their standard errors are included in Table S3. Trueness and precision (n = 5) were assessed by recovery studies performed in ultrapure water at 10 ng mL−1 and in (both deconjugated and non-deconjugated) urine at three levels, 5, 50, and 200 ng mL−1 of all analytes (20 ng mL−1 of ISs). Urine aliquots spiked only with IS (non-spiked) were processed at the same time to account for analyte background levels in this matrix.
Matrix effects (ME) were evaluated as the non-IS corrected recovery of spiked pooled urine samples from 20 different individuals (50 ng mL−1). MDLs and MQLs were calculated from the urine samples spiked with 5 ng mL−1 and extrapolating this concentration to that corresponding to a signal-to-noise ratio (S/N) of 3 and 10, respectively.
Bisphenol stability in urine
Bisphenol stability was tested in order to verify if the target compounds were stable in urine samples during the period of sampling and storage. Experiments were performed in triplicate where 1.68 mL of urine was spiked with 320 µL of a mixture solution (final concentration 400 ng mL−1), containing the six bisphenols. Then, urine samples were stored in amber glass vials at 22 ± 2 °C. Aliquots of 200 µL (n = 3) were collected at time 0 and after 1.5, 3, 5, 8, 24, and 48 h. They were filtered through 0.22 µm hydrophilic PVDF syringe-driven filters, diluted four times with ultrapure water, and spiked with 20 ng mL−1 of ISs. Subsequently, these samples were submitted to the final online SPE-LC–MS/MS methodology.
Furthermore, freezing storage stability (− 18 ± 2 °C) was also tested. Three different urine samples, spiked with 400 ng mL−1 of analytes, were stored in the same material containers, and kept in the same freezer as volunteers’ urine samples for 4 weeks. On the other hand, creatinine stability has already been demonstrated in previous works, showing good stability for months at different temperatures [35, 36].
Assessment of human exposure to bisphenols
The concentration of each target compound found in urine samples (in ng mL−1) was calculated by the IS calibration method (IS level: 20 ng mL−1). Then, creatinine-adjusted concentrations (in µg of bisphenol per g of creatinine) were calculated.
Additionally, human intake of bisphenols (µg kg−1 day−1) was estimated by considering the average daily urine volume of 1.57 L per individual [37] and the weighted mean of the population weight according to a summary of scientific studies evaluated and published by the NCD Risk Factor Collaboration. The estimated average body mass for men and women in Spain was 84.0 and 65.9 kg, respectively [38].
Quality control/quality assurance
Quality control (QC) samples were prepared spiking a control pooled urine sample with 100 ng mL−1 of analytes (20 ng mL−1 of ISs) and processed following the optimized methodology. Two QC samples per batch (each 20 urine samples) were injected to test for method stability (tolerance set to 60–140% range, see “Method performance”). Similarly, different blanks were analyzed within batches to ensure the lack of (cross)contamination. These included system blanks (chromatographic runs without injection), process blanks (ultrapure water spiked with the IS), and storage blanks (sample tubes containing synthetic urine, prepared as described by Laube et al. [39], and stored for up to 4 weeks).
Statistical analysis
Statistical analysis was performed using the software Statgraphics Centurion 18. Statistical correlation (α = 0.05) within the urinary concentration of BPF, BPS, and volunteers’ age was assessed by a Spearman rank correlation (data non-normal distributed). This same software was also used for creating and analyzing the design of experiments used during enzymatic deconjugation optimization (Text S2).
Statistical differences (α = 0.05) in the BPF and BPS urinary concentrations between groups of different genders and tobacco use were evaluated by the Mann–Whitney test and statistical differences between the residence environment were evaluated by a Kruskal–Wallis test, with a post hoc Bonferroni correction. Data was graphically presented with the R ggstatsplot package [40]. The values of BPF and BPS below the MDL and MQL were substituted by MQL/2 and MDL/2, respectively. No statistical analysis for BPA was performed due to the high percentage of samples below MQL.
Results and discussion
Enzymatic hydrolysis
The hydrolysis of urinary conjugates is critical to estimate the real exposure of bisphenols. β-glucuronidase is the most commonly used enzyme for bisphenols deconjugation at 37 °C [41, 42]. Many commercially available β-glucuronidase enzymes also have sulfatase activity, so that both phase II type of metabolites, glucuronides and sulfates, can be deconjugates. Although some former studies exist, they use different enzymes [30, 42,43,44]; thus, the deconjugation process was carefully optimized again by a design of experiments approach, as described in Text S1, with the glucuronide and sulfate metabolites available in the laboratory.
The transformation yield was calculated by measuring the concentration of BPA, BPS, and BPF formed and employed to select the best conditions for the hydrolysis of urinary metabolites. The analysis of the results obtained showed that the formation of BPA (from its mono- and bis-sulfate and mono- and bis-glucuronide) was non-statistically affected by any of the factors (time and enzyme concentration) considered (Figure S1). Thus, BPA conjugates are easily converted to BPA under all conditions tested. On the other hand, the formation of BPF and BPS was statistically affected by both the incubation time and the concentration of enzyme, without significant interaction between factors (Figure S1). As shown in the Pareto charts (Figure S1); however, the deconjugation yield for the metabolites of these two bisphenols is linearly and positively affected by time, while there is a significant curvature on the enzyme concentration (both B and BB terms are statistically significant). As shown in Fig. 2 and S2, where the estimated response surfaces for BPF and BPS are presented respectively, the deconjugation yield does not further increase beyond ca. 600 units of the enzyme. Thus, the optimal values were set at 5 h of incubation and 700 units of β-glucuronidase.
Chromatographic eluent modifier
Chromatographic separation was performed on a Luna C18 column (150 × 2 mm I.D., 3 µm particle size) at 0.2 mL min−1, so as not to surpass the maximum pressure of Strata-X cartridges (260 bar). Ammonium acetate was initially tested, but it afforded much less signal than NH4F, which has already been shown in the literature to provide better ionization efficiency in negative mode ESI [45]. Then, different concentrations of NH4F were investigated (0.1, 0.2, 0.5, 1, 2, and 5 mM). Finally, 2 mM NH4F was selected due to the higher relative response observed in spiked (10 ng mL−1, n = 3) urine samples (Figure S3). A good peak shape was obtained for the six bisphenols in these conditions (Figure S4).
SPE optimization
Sample preconcentration and clean-up were performed by online SPE in order to maximize sample throughput. This approach had been already previously employed to determine some of the bisphenols, but not all, considered in this work (Table S4) [42,43,44, 46, 47]. Among the different available sorbents, Strata-X was used due to its hydrophobic-hydrophilic balance, as this is a co-polymer of styrene–divinylbenzene modified by introducing pyrrolidone groups [48].
A dual eluent system consisting of (A1) ultrapure water and (B1) MeOH at 1 mL min−1 was used as a sample carrier and for cartridge clean-up and back-conditioning. Different modifiers of the aqueous phase were considered, viz. 0.1% formic acid, 0.1% acetic acid, and a sodium acetate buffer at pH 5 (in this case at three concentration levels, 5, 15, and 25 mM). The use of 15 mM of sodium acetate buffer at pH 5 was finally selected, as it showed the best peak shape and signal intensity for target analytes, being BPS the most critical compound (Figure S5).
The SPE gradient started at 0% B1 for 2 min to load the sample into the Strata-X cartridge, and after that, a clean-up step of 3 min with different percentages of B1 (10, 20, 40, and 60%) was investigated. Finally, 40% B1 was selected, as the higher % of MeOH allowed the removal of potential matrix interferences without eluting the target compounds from the online SPE sorbent (data not shown). Finally, to improve peak focusing, the quaternary pump was programmed again to aqueous conditions (0% B1) 2 min before the 10-port vale was switched for elution towards the chromatographic column. During the chromatographic gradient, the quaternary pump flow was lowered to 0.05 mL min−1 to reduce solvent expenditure, and subsequently, a washing step with 100% B1 of the Strata-X cartridge was included before the subsequent injection (see Table 1 for detailed information).
Stability of bisphenols in urine
Stability tests were conducted for the target bisphenols in urine following the protocol explained in “Materials and methods.”
The study of sampling stability showed that the six bisphenols were stable for 48 h at room temperature (Figure S6). As urine samples were collected every morning by sanitary employers and stored at 4 °C until they were taken to the laboratory the same morning, degradation during the urine sampling is thus not expected.
The 4-week stability study at − 18 °C did not show any potential loss of bisphenols in urine tubes during these weeks, with % absolute recoveries (%R) between 87 and 119% (Table 3). Some formerly published studies also reported that BPA, BPF, and BPS are chemically stable in frozen urine for several months [42, 49, 50], but the stability of the remaining bisphenols was not tested in the literature before.
Method performance
Trueness and precision of the online SPE-LC–MS/MS method were assessed through recovery studies performed with ultrapure water and urine (with and without enzymatic deconjugation) at three different concentration levels with three different urine samples (Table 3). For BPA, BPB, BPE, BPF, and BPS, the recoveries ranged between 74 and 120%, with RSDs between 2 and 10%. The exception was BPAF, whose recoveries (even when corrected with BPA-d6) were poor and highly variable, particularly in the deconjugated samples (11 to 40%). MDLs ranged from 0.015 to 0.66 ng mL−1, and MQLs from 0.049 to 2.2 ng mL−1 (Table 3).
ME were investigated by assessing the absolute recovery with twenty different urine deconjugated samples from different individuals. As presented in Fig. 3a, a strong to very strong signal suppression was observed. Furthermore, such ME were highly variable among samples. For instance, in the case of BPS, % ME average was 32% (median = 27%) but it spanned from 17 up to 60%, depending on the sample. In this case as well as for BPA, the deuterated IS could correct for this variation. Similarly, BPF, BPE, and BPB pose ME values similar to those of BPA, so their response could be corrected by BPA-d6 (Fig. 3b). However, BPAF suffered from an extremely strong signal suppression (average and median ME = 2%), so neither BPA-d6 nor BPS-d8 were suitable ISs to correct its matrix effect (Fig. 3b).
The proposed method was compared to other available online SPE-LC–MS/MS methods for the determination of bisphenols in urine [42,43,44, 47, 51] (Table S4). Most of the literature studies focus on BPA and the most prominent substitutes, BPF and BPS, while BPAF, BPB, and BPE have been barely studied in urine samples. The trueness for BPA, BPB, BPE, BPF, and BPS was comparable with published methodologies [42, 47]. In the case of BPAF, the only study available [43] used 13C12-BPA to correct the signal of BPAF, even when reporting very different ME for both compounds (%ME 3% BPA and 69% BPAF) and surprisingly a good IS-corrected recovery in urine was obtained. Nevertheless, in our study, none of the two available deuterated bisphenols was able to provide acceptable trueness for this compound.
As a drawback, for BPAF, it would be necessary to purchase the isotopically labelled analogue or to measure its concentration by standard addition, whenever found in the samples. However, this compound was not detected in the urine samples (see next section).
Analysis of urine samples
Urinary concentrations
The validated methodology was applied to the analysis of a total of 435 samples of human urine (data summarized in Table 4, full data presented in the ZENODO repository: https://doi.org/10.5281/zenodo.10477935). Each analytical batch included two QC samples (100 ng mL−1 of analytes) to test for method performance during analysis. Average recoveries in the QC samples remained in the 89–114% for all bisphenols, except, as mentioned for BPAF (19%) and within the 60–140% tolerance range, with good repeatability (%RSD < 5%).
Only BPA, BPF, and BPS were detected in urine samples. BPF was the substance more frequently detected (present in 96.8% of the urine samples) with median and maximum concentrations of 14.9 and 125 ng mL−1, respectively (median = 18.9 µg g−1 and maximum = 172 µg g−1 when normalized to creatinine). The second most prevalent bisphenol was BPS (detected in 83.6% of the samples) with median and maximum concentrations of 0.90 and 80.1 ng mL−1, respectively (median = 0.99 µg g−1, maximum = 173 µg g−1 when normalized to creatinine). Finally, BPA was detected in 16.6% of the samples only with a maximum concentration of 103 ng mL−1 (289 µg g−1 creatinine-corrected). In this case, the median would be < MDL.
According to the literature (see Table S5 for a compilation of recent studies), the HBM study by Frederisken et al. [52] conducted between 2009 and 2017 in young Danish men has identified a slightly decreasing trend in BPA detection frequency, yet a higher increasing trend of substitutes in 2017, especially BPS. Nevertheless, recent studies (Table S5) conducted in Spain [53, 54] and other countries, e.g., Australia and Norway [43, 55], have reported a much higher detection frequency of BPA, with concentrations typically higher than those found in our study, though variable. The literature presents different findings regarding the detection frequency and levels of BPF and BPS so there is a similar prevalence for both alternatives, as in our study. Overall, the results for the population considered in this work point towards a relevant decrease in BPA exposure and an increase in BPF and BPS.
Estimated human intake
Urinary concentrations were converted to estimate human intake, as described in “Materials and methods” and compared with the TDI recently set by EFSA at 0.2 ng kg−1 day−1 for BPA (Table 4). In the case of BPA, all the samples in which this bisphenol was detected (estimated intake up to 1920 ng kg−1 day−1) would be above the TDI level. Moreover, following the BfR recommendation [24], if the estimated human intake for BPF is compared to TDI for BPA, all samples where BPF was detected (i.e., 421) would again be above that threshold. This fact evidences the need for actions to limit exposure to bisphenols, particularly taking into consideration the uncertain situation as regards the safety of bisphenols other than BPA in terms of their toxicological effects.
Influence of sociodemographic factors
Population’s characteristics as well as the results in terms of concentrations and estimated human intake are summarized in Table S2 and Table 4 and detailed in the ZENODO repository (https://doi.org/10.5281/zenodo.10477935). The studied population consisted of 67.6% females and 32.4% males in the 32–66 years old range. Also, the population was classified according to tobacco use and residence location (urban, suburban, and rural). The potential association between BPS and BPF and the sociodemographic factors were studied as detailed in the section “Statistical analysis.” BPA was not considered ought to its low detection frequency.
A Spearman’s rank correlation analysis was carried out to investigate the relationship between age and BPF and BPS creatinine-adjusted concentration. There was a significant positive correlation (rho = 0.3194, p-value < 0.0001) between BPF and BPS concentrations (Table 5). This fact was previously observed in other studies [44, 52, 55] and may simply be related to the fact that people with higher levels of BPF and BPS are those who are more exposed to plastics and their additives. Furthermore, a very weak positive correlation (rho = 0.09536, p-value = 0.0478) was denoted between BPS concentration with age, which may point to the accumulation of this substance by older individuals (Table 5). However, this needs to be taken with caution, given the weak correlation.
Gender and tobacco use differences in urinary creatine-corrected BPF and BPS concentrations were examined by a Mann–Whitney non-parametric test and residence environment by a Kruskal–Wallis non-parametric test, as detailed in the section of statistical analysis. Higher median concentrations were obtained for females (Fig. 4), but this was only statistically significant for BPF (p-value: 9.79 × 10−8). Several studies have reported the same phenomenon for bisphenols, where the urine concentration on a ng mL−1 basis was higher in men; however, after correction for creatinine, the conclusion was reversed [44, 47, 49]. Hence, when assessing gender-related variations in exogenous substances, it is crucial to consider factors like bioaccumulation or metabolism, which can vary between women and men [56].
The two remaining factors were not statistically significant (Figures S7 and S8). The median creatine-corrected concentration for both bisphenols (Figure S8b) was higher in urban (median 1.09 µg g−1 for BPS and 18.92 µg g−1 for BPF) and suburban environments median (0.98 µg g−1 and 19.32 µg g−1 for BPF) than in rural ones (0.72 µg g−1 and 16.46 µg g−1 for BPF).
Conclusions
An online SPE-LC–MS/MS methodology has been developed for the determination of six bisphenols (BPA, BPAF, BPB, BPE, BPF, and BPS) and employed for the analysis of 435 human urine samples from a non-occupational exposure population. The method showed satisfactory performance figures, despite the variable matrix effects, for five bisphenols. However, the exception was BPAF, for which the technique exhibited notably low absolute recoveries, primarily attributed to the absence of an appropriate internal standard to account for the extreme matrix effects.
Urinary concentration levels suggest that the frequency of detection of BPA is decreasing while its most prominent alternatives, BPF and BPS, is increasing. Nevertheless, BPA exposure is still found at levels above the TDI, posing a risk to human health. Although no TDI exists for BPF and BPS, they may also represent a relevant human risk. Therefore, actions need to be taken to minimize exposure to these chemicals. Stratification by gender showed significantly higher levels of BPF in women than men.
References
Lehmler H-J, Liu B, Gadogbe M, Bao W. Exposure to bisphenol A, bisphenol F, and bisphenol S in U.S. adults and children: the National Health and Nutrition Examination Survey 2013–2014. ACS Omega. 2018;3(6):6523–32.
Vasiljevic T, Harner T. Bisphenol A and its analogues in outdoor and indoor air: properties, sources and global levels. Sci Total Environ. 2021;789: 148013.
Hahladakis JN, Velis CA, Weber R, Iacovidou E, Purnell P. An overview of chemical additives present in plastics: migration, release, fate and environmental impact during their use, disposal and recycling. J Hazard Mater. 2018;344:179–99.
Fasano E, Bono-Blay F, Cirillo T, Montuori P, Lacorte S. Migration of phthalates, alkylphenols, bisphenol A and di(2-ethylhexyl)adipate from food packaging. Food Control. 2012;27(1):132–8.
Buckley JP, Kim H, Wong E, Rebholz CM. Ultra-processed food consumption and exposure to phthalates and bisphenols in the US National Health and Nutrition Examination Survey, 2013–2014. Environ Int. 2019;131: 105057.
Hoekstra EJ, Simoneau C. Release of bisphenol A from polycarbonate—a review. Crit Rev Food Sci Nutr. 2013;53(4):386–402.
Freire C, Molina-Molina J-M, Iribarne-Durán LM, Jiménez-Díaz I, Vela-Soria F, Mustieles V, et al. Concentrations of bisphenol A and parabens in socks for infants and young children in Spain and their hormone-like activities. Environ Int. 2019;127:592–600.
Molina-Molina JM, Jiménez-Díaz I, Fernández MF, Rodriguez-Carrillo A, Peinado FM, Mustieles V, et al. Determination of bisphenol A and bisphenol S concentrations and assessment of estrogen- and anti-androgen-like activities in thermal paper receipts from Brazil, France, and Spain. Environ Res. 2019;170:406–15.
vom Saal FS, Akingbemi BT, Belcher SM, Birnbaum LS, Crain DA, Eriksen M, et al. Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol. 2007;24(2):131–8.
Lang IA. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA. 2008;300(11):1303.
Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS. Association of urinary bisphenol A concentration with heart disease: evidence from NHANES 2003/06. PLoS ONE. 2010;5(1): e8673.
Kharrazian D. The potential roles of bisphenol A (BPA) pathogenesis in autoimmunity. Autoimmune Dis. 2014;2014:1–12.
Ziv-Gal A, Flaws J. Evidence for bisphenol A-induced female infertility: a review (2007–2016). Fertil Steril. 2016;106(4):827–56.
European Comission. Commision Regulation (EU) 2018/213 of 12 February 2018 on the use of bisphenol A in varnishes and coatings intended to come into contact with food and amending Regulation (EU) No 10/2011 as regards the use of that substance in plastic food contact materials. Off J Eur Union. 2018;L41/6-L41/12.
European Comission. Commision Directive 2011/8/EU of 28 January 2011 amending Directive 2002/72/EC as regards the restriction of use of Bisphenol A in plastic infant feeding bottles. Off J Eur Union. 2011;L26/11-L26/14.
EFSA Panel on Food Contact Materials, Lambré C, Barat Baviera JM, Bolognesi C, Chesson A, Cocconcelli PS, et al. Re-evaluation of the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs. EFSA J. 2023;21(4):e06857.
US-EPA. Biphenol A Action Plan - U.S. Environmental Protection Agency 2010. Available from: https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/bisphenol-bpa-summary. Accessed March 2024
US-EPA. Chemical Assessment Summary for Bisphenol A; CASRN 80–05–7. 1988. Available from: https://iris.epa.gov/static/pdfs/0356_summary.pdf. Accessed March 2024
Chen D, Kannan K, Tan H, Zheng Z, Feng Y-L, Wu Y, et al. Bisphenol analogues other than BPA: environmental occurrence, human exposure, and toxicity—a review. Environ Sci Technol. 2016;50(11):5438–53.
Skledar DG, Mašič LP. Bisphenol A and its analogs: do their metabolites have endocrine activity? Environ Toxicol Pharmacol. 2016;47:182–99.
Le Fol V, Aït-Aïssa S, Sonavane M, Porcher J-M, Balaguer P, Cravedi J-P, et al. In vitro and in vivo estrogenic activity of BPA, BPF and BPS in zebrafish-specific assays. Ecotoxicol Environ Saf. 2017;142:150–6.
Wang R, Fei Q, Liu S, Weng X, Liang H, Wu Y, et al. The bisphenol F and bisphenol S and cardiovascular disease: results from NHANES 2013–2016. Environ Sci Eure. 2022;34(1):1–10.
EFSA. Assessment of new information on bisphenol S (BPS) submitted in response to the Decision1 under REACH Regulation (EC) No 1907/2006. EFSA J. 2020:1–39. Available from: https://www.efsa.europa.eu/fr/supporting/pub/en-1844. Accessed March 2024
European Chemical Agency. Group assessment of bisphenols identifies need for restriction 2022. Available from: https://echa.europa.eu/-/group-assessment-of-bisphenols-identifies-need-for-restriction. Accessed March 2024
Thayer KA, Doerge DR, Hunt D, Schurman SH, Twaddle NC, Churchwell MI, et al. Pharmacokinetics of bisphenol A in humans following a single oral administration. Environ Int. 2015;83:107–15.
Le Fol V, Aït-Aïssa S, Cabaton N, Dolo L, Grimaldi M, Balaguer P, et al. Cell-specific biotransformation of benzophenone-2 and bisphenol-S in zebrafish and human in vitro models used for toxicity and estrogenicity screening. Environ Sci Technol. 2015;49(6):3860–8.
Khmiri I, Côté J, Mantha M, Khemiri R, Lacroix M, Gely C, et al. Toxicokinetics of bisphenol-S and its glucuronide in plasma and urine following oral and dermal exposure in volunteers for the interpretation of biomonitoring data. Environ Int. 2020;138: 105644.
Mustieles V, D’Cruz SC, Couderq S, Rodríguez-Carrillo A, Fini J-B, Hofer T, et al. Bisphenol A and its analogues: a comprehensive review to identify and prioritize effect biomarkers for human biomonitoring. Environ Int. 2020;144: 105811.
Teeguarden JG, Twaddle NC, Churchwell MI, Yang X, Fisher JW, Seryak LM, et al. 24-hour human urine and serum profiles of bisphenol A: evidence against sublingual absorption following ingestion in soup. Toxicol Appl Pharmacol. 2015;288(2):131–42.
Wang H, Tang S, Zhou X, Gao R, Liu Z, Song X, et al. Urinary concentrations of bisphenol analogues in the south of China population and their contribution to the per capital mass loads in wastewater. Environ Res. 2022;204: 112398.
Pinguet J, Kerckhove N, Eljezi T, Lambert C, Moreau E, Bernard L, et al. New SPE-LC-MS/MS method for the simultaneous determination in urine of 22 metabolites of DEHP and alternative plasticizers from PVC medical devices. Talanta. 2019;198:377–89.
Koch HM, Gonzalez-Reche LM, Angerer J. On-line clean-up by multidimensional liquid chromatography-electrospray ionization tandem mass spectrometry for high throughput quantification of primary and secondary phthalate metabolites in human urine. J Chromatogr B. 2003;784(1):169–82.
Dwivedi P, Zhou X, Powell TG, Calafat AM, Ye X. Impact of enzymatic hydrolysis on the quantification of total urinary concentrations of chemical biomarkers. Chemosphere. 2018;199:256–62.
Hernández F, Fabregat-Safont D, Campos-Mañas M, Quintana JB. Efficient validation strategies in environmental analytical chemistry: a focus on organic micropollutants in water samples. Annu Rev Anal Chem. 2023;16(1):401–28.
Spierto FW, Hannon WH, Gunter EW, Smith SJ. Stability of urine creatinine. Clin Chim Acta. 1997;264(2):227–32.
Parekh RS, Kao WHL, Meoni LA, Ipp E, Kimmel PL, La Page J, et al. Reliability of urinary albumin, total protein, and creatinine assays after prolonged storage: the family investigation of nephropathy and diabetes. Clin J Am Soc Nephrol. 2007;2(6):1156–62.
González-Mariño I, Rodil R, Barrio I, Cela R, Quintana JB. Wastewater-based epidemiology as a new tool for estimating population exposure to phthalate plasticizers. Environ Sci Technol. 2017;51(7):3902–10.
World Data. Average sizes of men and women 2023. Available from: https://www.worlddata.info/average-bodyheight.php. Accessed March 2024
Laube N, Mohr B, Hesse A. Laser-probe-based investigation of the evolution of particle size distributions of calcium oxalate particles formed in artificial urines. J Cryst Growth. 2001;233(1):367–74.
Patil I. Visualizations with statistical details: the “ggstatsplot” approach. J Open Source Softw. 2021;6(61):3167.
Moos RK, Angerer J, Wittsiepe J, Wilhelm M, Brüning T, Koch HM. Rapid determination of nine parabens and seven other environmental phenols in urine samples of German children and adults. Int J Hyg Environ Health. 2014;217(8):845–53.
Zhou X, Kramer JP, Calafat AM, Ye X. Automated on-line column-switching high performance liquid chromatography isotope dilution tandem mass spectrometry method for the quantification of bisphenol A, bisphenol F, bisphenol S, and 11 other phenols in urine. J Chromatogr B. 2014;944:152–6.
Heffernan AL, Thompson K, Eaglesham G, Vijayasarathy S, Mueller JF, Sly PD, et al. Rapid, automated online SPE-LC-QTRAP-MS/MS method for the simultaneous analysis of 14 phthalate metabolites and 5 bisphenol analogues in human urine. Talanta. 2016;151:224–33.
Jo MJ, Park J-H, An K-A, Choi H, Kang Y-s, Hwang M. Quantification of bisphenols in Korean urine using online solid-phase extraction-high-performance liquid chromatography-tandem mass spectrometry. Environ Toxicol Pharmacol. 2020;80:103491.
Lopardo L, Petrie B, Proctor K, Youdan J, Barden R, Kasprzyk-Hordern B. Estimation of community-wide exposure to bisphenol A via water fingerprinting. Environ Int. 2019;125(January):1–8.
Ye X, Kuklenyik Z, Needham LL, Calafat AM. Quantification of urinary conjugates of bisphenol A, 2,5-dichlorophenol, and 2-hydroxy-4-methoxybenzophenone in humans by online solid phase extraction–high performance liquid chromatography–tandem mass spectrometry. Anal Bioanal Chem. 2005;383(4):638–44.
Koch HM, Kolossa-Gehring M, Schröter-Kermani C, Angerer J, Brüning T. Bisphenol A in 24 h urine and plasma samples of the German Environmental Specimen Bank from 1995 to 2009: a retrospective exposure evaluation. J Expo Sci Environ Epidemiol. 2012;22(6):610–6.
Fontanals N, Marcé RM, Borrull F. Materials for solid-phase extraction of organic compounds. Separations. 2019;6(4):56.
Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect. 2005;113(4):391–5.
Nepomnaschy PA, Baird DD, Weinberg CR, Hoppin JA, Longnecker MP, Wilcox AJ. Within-person variability in urinary bisphenol A concentrations: measurements from specimens after long-term frozen storage. Environ Res. 2009;109(6):734–7.
Ye X, Kuklenyik Z, Needham LL, Calafat AM. Automated on-line column-switching HPLC-MS/MS method with peak focusing for the determination of nine environmental phenols in urine. Anal Chem. 2005;77(16):5407–13.
Frederiksen H, Nielsen O, Koch HM, Skakkebaek NE, Juul A, Jørgensen N, et al. Changes in urinary excretion of phthalates, phthalate substitutes, bisphenols and other polychlorinated and phenolic substances in young Danish men; 2009–2017. Int J Hyg Environ Health. 2020;223(1):93–105.
Peinado FM, Lendínez I, Sotelo R, Iribarne-Durán LM, Fernández-Parra J, Vela-Soria F, et al. Association of urinary levels of bisphenols A, F, and S with endometriosis risk: preliminary results of the EndEA Study. Int J Environ Res Public Health. 2020;17(4):1194.
Sanchis Y, Coscollà C, Corpas-Burgos F, Vento M, Gormaz M, Yusà V. Biomonitoring of bisphenols A, F, S and parabens in urine of breastfeeding mothers: exposure and risk assessment. Environ Res. 2020;185: 109481.
Husøy T, Andreassen M, Hjertholm H, Carlsen MH, Norberg N, Sprong C, et al. The Norwegian biomonitoring study from the EU project EuroMix: levels of phenols and phthalates in 24-hour urine samples and exposure sources from food and personal care products. Environ Int. 2019;132:105103
Arrebola JP, Martin-Olmedo P, Fernandez MF, Sanchez-Cantalejo E, Jimenez-Rios JA, Torne P, et al. Predictors of concentrations of hexachlorobenzene in human adipose tissue: a multivariate analysis by gender in Southern Spain. Environ Int. 2009;35(1):27–32.
Acknowledgements
We are grateful to the Galician Directorate for Public Health (Dirección Xeral de Saúde Pública da Xunta de Galicia), especially to Xurxo Hervada Vidal and Alberto Malvar Pintos, the Galician Occupational Risk Prevention Service (Servizo de Prevención de Riscos Laborales, Xunta de Galicia), especially to Pablo Díaz Vázquez and the company Cualtis (María Teresa Magdalena Iglesias, José Acuña Vilas, María José Sanjiao Otero, Verónica Rouco López, Johana Betancourt Cañas, Marco Bello Hermida and Isidro Rivadulla Lema), for their collaboration during the human urine collection campaign. We also acknowledge Agilent Technologies for the kind lend of the LC-MS/MS system.
Funding
Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This work was funded by the Spanish Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033 (ref. PID2020-117686RB-C32) and Consellería de Cultura, Educación y Universidades da Xunta de Galicia (ref. ED481A-2020/258 and ED431C 2021/06).
Author information
Authors and Affiliations
Contributions
Conceptualization: Rosa Montes, Rosario Rodil, José Benito Quintana. Visualization: Rosa Montes, Rosario Rodil, José Benito Quintana. Methodology: Andrea Estévez-Danta. Validation: Andrea Estevez-Danta, Rosa Montes, Rosario Rodil, José Benito Quintana. Formal analysis: Andrea Estévez-Danta, Rosa Montes, Rosario Rodil, José Benito Quintana. Investigation: Andrea Estévez-Danta. Resources: Rosario Rodil, José Benito Quintana. Funding acquisition: Rosario Rodil, José Benito Quintana. Supervision: Rosa Montes, Rosario Rodil, José Benito Quintana. Writing—original draft: Andrea Estévez-Danta. Writing—review and editing: all authors.
Corresponding authors
Ethics declarations
Ethics approval
Ethical consent for the study was obtained from the Research Ethics Committee of the Xunta de Galicia (Code 2019/545).
Conflict of interest
The authors declare no competing interests.
Source of biological material
Urine samples were collected from volunteers and anonymized; informed consent from each participant was obtained and stored properly following the requirements established by the ethical approval protocol.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Estévez-Danta, A., Rodil, R., Quintana, J.B. et al. Determination of the urinary concentrations of six bisphenols in public servants by online solid-phase extraction-liquid chromatography tandem mass spectrometry. Anal Bioanal Chem 416, 4469–4480 (2024). https://doi.org/10.1007/s00216-024-05386-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-024-05386-7